Pinsent Masons advises Primary Capital Partners on management buy-out of Foster & Freeman

16 Aug 2019 | 09:35 am | 2 min. read

International law firm, Pinsent Masons, has advised Primary Capital Partners on its management buy-out of British engineering company Foster & Freeman.

The Pinsent Masons team advising Primary Capital Partners included Partner Nicole Livesey, Partner Ed Stead, Associate Paul Krivosic and Associate David Meisel.

Primary is a leading provider of private equity finance for UK-based growth companies valued between £20 million and £100 million.

Foster & Freeman are one of the top forensic science equipment suppliers in the world, exporting market-leading, and in many cases unique, products from the UK to more than 160 countries worldwide. The business has a world-class R&D team with a track record in producing industry-leading technology, including the new Recover product which is the only technology available worldwide for developing fingermarks on fired ammunition casings / bomb fragments.

The buy-out continues Primary’s strong track record of investing in high-quality, differentiated niche leaders in specialist manufacturing and industrial products and services.

Nicole Livesey, Partner at Pinsent Masons commented:
"We are proud to have provided legal support to Primary Capital Partners as they now work alongside Foster & Freeman to help them deliver the next phase of growth for the business and invest further in to R&D and new product development to accelerate their technological leadership."

Latest press releases

Show me all press releases

Pinsent Masons advises MJM Group on another M&A transaction in the Polish insurance sector

Multinational law firm Pinsent Masons has advised MJM Group, one of the leading brokerage groups in the insurance and reinsurance market, on the acquisition of a 100% stake in Certo Broker and XILIUM. Certo Broker specialises in the distribution of group and health insurance products, while XILIUM provides a digital platform for the administration of group life insurance programmes and health insurance policies.

Pinsent Masons advises Nichols plc on Vit Hit acquisition

Multinational law firm Pinsent Masons has advised British multinational soft drinks company Nichols plc (Nichols) on its acquisition of Vit Hit Limited (VITHIT) for €75 million.

Pinsent Masons appointed to Government legal panel for public sector

Multinational law firm Pinsent Masons has been named as a supplier on Government Commercial Agency’s (GCA) RM6374 Legal Panel for Public Sector framework, a major legal services framework expected to be a key route to market for public sector organisations across the UK over the coming years.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises MJM Group on another M&A transaction in the Polish insurance sector

Multinational law firm Pinsent Masons has advised MJM Group, one of the leading brokerage groups in the insurance and reinsurance market, on the acquisition of a 100% stake in Certo Broker and XILIUM. Certo Broker specialises in the distribution of group and health insurance products, while XILIUM provides a digital platform for the administration of group life insurance programmes and health insurance policies.

Pinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania

Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.

Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis

Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.